BCL-xL: Time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells

Cell Death and Differentiation

Volumn 13, Issue 7, 2006, Pages 1156-1169

  Weiler, M ^a   Bahr O ^a   Hohlweg, U ^a   Naumann, U ^a   Rieger, J ^a   Huang, H ^b   Tabatabai, G ^a   Krell, H W ^c   Ohgaki, H ^b   Weller, M ^a   Wick, Wolfgang ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Anoikis; BCL x; Glioma; Invasiveness; Metalloproteinase; Tet On system; TGF

Indexed keywords

ANTINEOPLASTIC AGENT; DOXYCYCLINE; GELATINASE A; INTEGRIN; MATRIX METALLOPROTEINASE 14; PROTEIN BCL XL; RO 28 2653; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; PROTEIN BCL X; TGFB2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CELL CLONE; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; DRUG SPECIFICITY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TIME; ANIMAL; BRAIN TUMOR; CELL LINE; CELL MOTION; CELL STRAIN 3T3; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; GLIOMA; IMMUNOBLOTTING; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SURVIVAL;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BRAIN NEOPLASMS; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; GLIOMA; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33745197969     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401786     Document Type: Article

References (35)

1. Bögler O and Weller M (2003) International Hermelin Brain Tumor Center Symposium on apoptosis. Cell Death Differ. 10: 1112-1115
2. L promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276: 12041-12048
3. L sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J. 23: 2146-2155
4. L, but not BCL-2, to the mitochondrial outer membrane. J. Cell Biol. 160: 53-64
5. Bourguignon LY, Zhu H, Shao L and Chen YW (2000) CD44 interaction with c-Src kinase promotes contraction-mediated cytoskeleton function and hyaluronic acid (HA)-dependent ovarian tumor cell migration. J. Biol. Chem. 276: 7327-7336
6. Hiscox S and Jiang WG (1997) Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/ scatter factor. Biochem. Biophys. Res. Commun. 233: 1-5
7. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD and Laerum OD (1990) Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res. 50: 6039-6044
8. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID and Johnston P (1997) Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab. Invest. 76: 565-577
9. Merzak A, McCrea S, Koocheckpour S and Pilkington GJ (1994) Control of human glioma cell growth, migration, and invasion in vitro by transforming growth factor beta 1. Br. J. Cancer 70: 199-203
10. 2. J. Neurosci. 21: 3360-3368
11. Uhl M, Aulwurm S, Wischhusen J, Weiler M, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wick W, Higgins L and Weller M (2004) SD-208, a novel TGF-β receptor I antagonist, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res. 64: 7954-7961
12. Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC and Weller M (1998) BCL-2 promotes migration and invasiveness of human glioma cells. FEBS Lett. 440: 419-424
13. Uhm J, Dooley N, Kyritsis A, Rao J and Gladson C (1999) Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin. Cancer Res. 5: 1587-1594
14. Nör J, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM and Polverini PJ (2001) Up-regulation of BCL-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res. 61: 2183-2188
15. Wild-Bode C, Weller M and Wick W (2001) Molecular determinants of glioma cell migration and invasion. J. Neurosurg. 94: 978-984
16. Ruoslahti E and Reed J (1999) New way to activate caspases. Nature 397: 479-480
17. Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F and Gudermann T (2003) Matrix metalloproteinase 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J. Biol. Chem. 278: 47307-47318
18. Wang H-G, Rapp UR and Reed JC (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629-638
19. Kroemer G (1997) The proto-oncogene BCL-2 and its role in regulating apoptosis. Nat. Med. 3: 614-620
20. L prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274: 1156-1163
21. Frisch SM and Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124: 619-626
22. Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons D-L, Akbar AN, Lord JM and Salmon M (1999) RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397: 534-539
23. Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A and Weller M (2004) RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response and inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res. 64: 7596-7603
24. Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC and Stack MS (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinase 2-expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279: 39042-39050
25. Li C, Fox CJ, Master SR, Bindokas VP, Chodosh LA and Thompson CB (2002) BCL-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc. Natl. Acad. Sci. USA 99: 9830-9835
26. Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH and Fontana A (1995) Local Fas/APO-1 (CD95) ligand-mediated tumor killing in vivo. Eur. J. Immunol. 25: 2253-2258
27. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
28. Wischhusen J, Naumann U, Ohgaki H, Rastinejad F and Weller M (2003) CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 22: 8233-8245
29. 1/2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. J. Immunol. 166: 7238-724330
30. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T, Werb Z, Baker A, Libert C, Krell HW, Foidart JM, Noel A and Rakic JM (2003) MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 17: 2290-2292
31. Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P and Ohgaki H (2000) Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res. 60: 6868-6874
32. Steinbach JP, Wolburg H, Klumpp A, Probst H and Weller M (2003) Hypoxia-induced cell death in human malignant glioma cells: Energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Cell Death Differ. 10: 823-832
33. Fulda S, Wick W, Weller M and Debatin KM (2002) Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med. 8: 808-815
34. Wild-Bode C, Weller M, Rimner A, Dichgans J and Wick W (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res. 61: 2744-2750
35. Kaplan EL and Meyer P (1958) Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481